Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kunihisa, Nakai"'
Autor:
Takashi, Yokoi, Shinichiro, Mori, Hiroyuki, Sugimoto, Yutaka, Komiyama, Yoshiko, Uemura, Riki, Tanijiri, Kunihisa, Nakai, Noriaki, Matsumoto, Katsuhiro, Zen, Ryuichi, Amakawa, Yuji, Kishimoto, Masahiro, Ieko, Hakuo, Takahashi, Shirou, Fukuhara
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 45(10)
A 61-year-old woman experienced a high fever with anemia and APTT prolongation after suffering a herpes zoster virus infection. Physical examination revealed a large splenomegaly without lymphadenopathy. Laboratory evaluations were positive for lupus
Autor:
Kunihisa, Nakai
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 61(9)
A number of reduced-intensity conditioning(RIC) regimens, which mainly consisted of potent immunosuppressive agents but not of myeloablative agents, has been explored in order to achieve successful engraftment and subsequent graft-versus-leukemia/tum
Autor:
Shin, Mineishi, Yoshinobu, Kanda, Takeshi, Saito, Kunihisa, Nakai, Atsushi, Makimoto, Masahiro, Kami, Ryuji, Tanosaki, Hiro, Wakasugi, Kensei, Tobinai, Yoichi, Takaue
Publikováno v:
British journal of haematology. 121(2)
To clarify the impact of graft-versus-host disease (GVHD) on the outcome of reduced-intensity stem cell transplantation (RIST), 40 patients who received RIST were compared with those who received conventional stem cell transplantation (CST). RIST reg
Autor:
Kunihisa, Nakai, Shin, Mineishi, Masahiro, Kami, Yoshinobu, Kanda, Ryuji, Tanosaki, Yoichi, Takaue
Publikováno v:
Haematologica. 88(1)
Autor:
Takeshi, Saito, Yoshinobu, Kanda, Masahiro, Kami, Kazunori, Kato, Nahoko, Shoji, Sachiyo, Kanai, Toshihiro, Ohnishi, Yoshifumi, Kawano, Kunihisa, Nakai, Toshie, Ogasawara, Hiroshi, Matsubara, Atsushi, Makimoto, Ryuji, Tanosaki, Kensei, Tobinai, Hiro, Wakasugi, Yoichi, Takaue, Shin, Mineishi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(4)
Cladribine (2-CdA) is a purine analogue that exhibits activity against a variety of hematological malignancies and has a potent immunosuppressive effect. We therefore performed a pilot study to evaluate the feasibility of a novel 2-CdA-based reduced-
Autor:
Kunihisa Nakai
Publikováno v:
Transplantation; Jun2003, Vol. 75 Issue 12, p2135, 10p